Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Cytrx Corp (OP: CYTR )

N/A UNCHANGED
Last Price Updated: 1:53 PM EDT, Oct 5, 2022 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Cytrx Corp

< Previous 1 2 Next >
CytRx Notes Orphazyme’s Regulatory Update from the FDA on Arimoclomol for Niemann-Pick Disease Type C
From CytRx Corporation
Via Business Wire
Orphazyme Wild Party At Risk As FDA Rejects Its Rare Neurodegenerative Disease Drug
Orphazyme A/S (NASDAQ: ORPH) shares, which have been extremely volatile of late, could come under pressure Friday following a regulatory setback. What Happened:... 
Via Benzinga
Exposures Product Safety
The Daily Biotech Pulse: Biogen Faces Another Clinical Setback, CureVac's COVID-19 Vaccine Study Fails, Moment Of Reckoning For Orphazyme
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs June 16) Alexion Pharmaceuticals,... 
Via Benzinga
Exposures COVID-19
A Look At Orpahzyme's Volatility Ahead Of Thursday's PDUFA Catalyst
After sobering down in the past three sessions, shares of Danish biopharma Orphazyme A/S (NASDAQ: ORPH) have taken off yet again. The Curious Case of The ‘Orphazyme Rally:... 
Via Benzinga
Why Novavax, Orphazyme, Avenue Therapeutics Shares Are Moving Monday
Novavax, Inc. (NASDAQ: NVAX), Orphazyme A/S (NASDAQ: ORPH) and Avenue Therapeutics, Inc. (NASDAQ: ATXI) are among the biggest movers among biopharma stocks Monday. Novavax Finally... 
Via Benzinga
The Week Ahead In Biotech: Takeda, Blueprint Medicines, Orphazyme, Eton On The Radar Ahead Of FDA Decisions, IPOs
Biotech stocks extended their gains in the week ended June 11, supported by the broader market strength and some stock-specific moves. The biggest biotech news of the week came in the form of approval... 
Via Talk Markets
Exposures Product Safety
The Week Ahead In Biotech: Takeda, Blueprint Medicines, Orphazyme, Eton On The Radar Ahead Of FDA Decisions, IPOs
Biotech stocks extended their gains in the week ended June 11, supported by the broader market strength and some stock-specific moves. The biggest biotech news of the week came in... 
Via Benzinga
Exposures Product Safety
CytRx to Present at Upcoming Investor Conferences
From CytRx Corporation
Via Business Wire
Attention Biotech Investors: Mark Your Calendar For June PDUFA Dates
The FDA review machinery worked overtime in May, completing reviews of several drug applications. Except for stray rejections or delays, the agency churned out mostly positive... 
Via Benzinga
Exposures Product Safety
CytRx Comments on Quarterly Results and Year-to-Date Progress
From CytRx Corporation
Via Business Wire
CytRx Notes Topline Data From Trial of Arimoclomol in Amyotrophic Lateral Sclerosis
From CytRx Corporation
Via Business Wire
< Previous 1 2 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.